H11.019

Clinical Causes: The exact cause of amyloid pterygium is not well understood, but it is believed to result from abnormal protein deposits known as amyloid, which can develop due to a variety of underlying factors. Chronic inflammation or injury to the eye may contribute to amyloid accumulation. Genetic predispositions might play a role in some cases, although research is ongoing to determine specific genetic links. Age-related changes or degenerative processes in the eye's tissue may influence the development of amyloid deposits. In some instances, systemic amyloidosis, a condition where amyloid protein builds up in multiple organs, might be associated with ocular amyloid deposits. Certain chronic eye conditions or inflammatory diseases could serve as underlying triggers for amyloid growth in the eye. Presence of other ocular or systemic diseases involving amyloid deposits can sometimes be linked to tight or recurring eye inflammation.

Key Symptoms: A visible, abnormal growth on the eye, typically on the conjunctiva extending onto the cornea. Discomfort or irritation in the affected eye. Blurry or decreased vision if the growth encroaches on the visual axis. Redness or inflammation of the eye surrounding the growth. Feeling of a foreign body or sensation of a scratchy eye. In some cases, the growth may be painless and only noticed through eye examination. Possible tearing or increased sensitivity to light depending on the size and location of the lesion.

Diagnosis Path: Diagnosis of amyloid pterygium involves a comprehensive eye examination by an ophthalmologist. A detailed ocular history and visual assessment are crucial. The ophthalmologist may use slit-lamp microscopy to examine the eye’s surface and identify the characteristic tissue growth. If amyloid deposits are suspected, further testing such as ocular biopsy may be performed to analyze tissue samples under a microscope, confirming amyloid presence. Additional imaging techniques, like anterior segment optical coherence tomography (AS-OCT), can help map the extent of the growth. In some cases, systemic evaluations are conducted to exclude or identify associated systemic amyloidosis or other underlying conditions.

Treatment Protocols: Treatment options depend on the size, location, and impact on vision or comfort. Common approaches include: - Observation: Small, asymptomatic lesions may only require regular monitoring. - Surgical removal: For larger or symptomatic growths affecting vision or causing discomfort, excision of the pterygium may be performed. - Managing underlying inflammation: Anti-inflammatory medications could be prescribed to reduce associated irritation. - Addressing systemic amyloidosis: If linked to systemic amyloid deposits, collaboration with other medical specialists is necessary for comprehensive management.